Institutional Cluster

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
BULLISH
Impact 5/10
Horizonweeks Processed2mo ago
Institutional cluster: 4 buyers, 1 sellers (bullish)
Actionable Insight ▲ Bullish

The cluster is dominated by active managers (Meitav, Assenagon) with high-conviction moves (NEW and DOUBLED), suggesting a catalyst-driven thesis. However, the 45-day reporting lag means these positions may already be unwound, and the lack of insider buying weakens the signal. Monitor for a subsequent 13F filing or a Form 4 cluster to confirm conviction. The stock's 86% analyst bullish consensus provides a supportive backdrop, but historical calibration warns of negative alpha at T+20 for similar setups.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+20d
TEVA ▲ +17.61% at T+20d
LONG call ✓ call won +17.61% · α vs SPY +13.49% · entry $31.00 → $36.46
Next anchor: T+60d in 11d
Latest observation: T+49 +22.55% FF3 residual α
Entry anchored
Jul 20, 12:05 PM ET
via exchange tick
T+1d
+1.13%
call +1.13% · α +0.29%
$31.35
settled 2mo ago
T+5d
-0.61%
call -0.61% · α -0.19%
$30.81
settled 2mo ago
T+20d
+17.61%
call +17.61% · α +13.49%
$36.46
settled 7w ago
T+60d
—
call — · α —
—
in 11d

Executive Summary

A bullish institutional cluster formed in TEVA during 2026-Q2, with four asset managers adding $400.6M in net new holdings, led by a $336.9M new position from Meitav Investment House and a $63.2M doubling by Assenagon Asset Management. The buying is concentrated among active managers, suggesting a shared thesis around TEVA's generic and specialty pharmaceutical pipeline, but the 45-day reporting lag and lack of insider buying (confluence score 18/100, divergent) temper conviction. Historical calibration shows TEVA reports at this impact level have underperformed the S&P 500 by an average of -2.12% at T+20 with a 40% win rate, and score-6 filings show a negative net alpha, warranting a cautious score.

Key Financial Metrics

Direction
accumulating
Buy Value
$441.5M
Sell Value
$3.7M
Net Flow
$399.6M

Institutional Positions

Net institutional flow: $399.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Meitav Investment HouseNEW+100%$336.9M$336.9M
Assenagon Asset ManagementDOUBLED+128.1%$103.5M$63.2M
Wealth Enhancement Advisory ServicesDOUBLED+128.1%$621.0K$372.0K
Farther Finance AdvisorsADD+29.3%$488.0K$151.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Davenport & CoTRIM-35.3%$3.7M-$1.0M

Key Facts

  • 4 institutional buyers added $400.6M in net new TEVA holdings in Q2 2026
  • Meitav Investment House initiated a new $336.9M position, the largest single move
  • Assenagon Asset Management doubled its stake to $103.5M
  • Only 1 seller (Davenport & Co) trimmed $1.0M, a negligible offset
  • No insider open-market buying was detected, creating a divergent signal with the institutional cluster
  • Historical TEVA reports at this impact level show a 40% win rate and negative alpha vs SPY at T+20

Financial Impact

4 institutions accumulated $400.6M in new TEVA holdings, while 1 seller reduced by $1.0M, for net institutional buying of $399.6M

institutional ownershipfloat demand

Risk Factors

  • 45-day 13F reporting lag: positions may have been reduced or exited since quarter-end
  • No insider buying to corroborate the institutional thesis (confluence score 18/100, divergent)
  • Historical TEVA reports at this impact level have a 40% win rate and negative alpha vs SPY at T+20
  • Single large position (Meitav $336.9M) dominates the cluster, creating concentration risk

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-TEVA-2026-Q2
31 reports for TEVA
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+20▲ +15.98%Apr 16, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%—
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%—
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%—
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%—
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%—
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%—
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%—
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%—
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%—
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%—
Showing 10 of 31

US Market Status

Market Closed — Opens Mon (64h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 20, 2026